Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional)

(NOT-OD-19-071) National Institutes of Health

Updates to NIH Policy on ESI Application Status

(NOT-OD-19-072) National Institutes of Health

Notice of Special Interest in Supporting Administrative Supplements for Fetal Alcohol Spectrum Disorders (FASD)

(NOT-AA-19-009) National Institute on Alcohol Abuse and Alcoholism

Notice of Special Interest: Administrative Supplements for Characterization and Further Development of Humanized Immune System (HIS) Mice

(NOT-AI-19-040)National Institute of Allergy and Infectious Diseases

Request for Information (RFI): Input on In-depth Stem Cell Characterization

(NOT-HL-19-679) National Heart, Lung, and Blood Institute

Notice of NIMHD Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)"

(NOT-MD-19-020) National Institute on Minority Health and Health Disparities

Requests for Applications

INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)

(RFA-OD-19-015)National Heart, Lung, and Blood Institute

Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)

(RFA-OD-19-016)National Heart, Lung, and Blood Institute

Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required)

(RFA-OD-19-018) National Heart, Lung, and Blood Institute